Virologic Response at 12 Months of Treatment Predicts Sustained Antiviral Efficacy in Patients with Adefovir-Treated Lamivudine-Resistant Chronic Hepatitis B

BACKGROUND/AIMS: The aim of our study was to define the potential role of virologic response at 12 months of treatment (VR12) in predicting subsequent virologic and clinical outcomes in adefovir (ADV)-treated lamivudine-resistant chronic hepatitis B. METHODS: Two hundred and four patients with lamiv...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Jung, Young Kul, Yeon, Jong Eun, Han, Woo Sik, Kim, Ji Hoon, Kim, Jeong Han, Park, Jong-Jae, Kim, Jae Seon, Bak, Young-Tae, Yoo, Wangdon, Hong, Sun Pyo, Kim, Soo-Ok, Kwon, So Young, Byun, Kwan Soo, Lee, Chang Hong
Формат: Artigo
Язык:Inglês
Опубликовано: The Korean Society of Gastroenterology; the Korean Society of Gastrointestinal Endoscopy; the Korean Association for the Study of the Liver; the Korean Society of Neurogastroenterology and Motility; Korean Association for the Study of Intestinal Diseases; Korean College of Helicobacter and Upper Gastrointestinal Research; Korean Society of Pancreatobiliary Diseases 2010
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2886940/
https://ncbi.nlm.nih.gov/pubmed/20559524
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl.2010.4.2.212
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы